Position in KURA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,240,518
+$561,398 QoQ
Shares Held
113,083
+35.4% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 220 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. KURA ranks #110 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in KURA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,240,518 | 113,083 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $679,120 | 83,533 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,662,718 | 160,031 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,902,530 | 327,970 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,941,555 | 336,492 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,236,468 | 338,859 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,601,341 | 298,662 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,939,124 | 252,770 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,497,719 | 218,442 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $4,784,231 | 224,296 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $3,232,392 | 224,784 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,787,218 | 195,967 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,507,701 | 142,505 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,063,592 | 86,966 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,316,910 | 106,117 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,658,896 | 121,442 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $2,226,030 | 121,442 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $1,366,767 | 84,998 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $810,544 | 57,896 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $950,190 | 50,731 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $791,110 | 37,943 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $905,091 | 32,016 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,045,641 | 32,016 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||